Primer on Multiple Sclerosis

Herausgeber: Giesser, Barbara S

• Broschiertes Buch

Produktbeschreibung

In this second edition of Primer on Multiple Sclerosis, the latest updates on therapeutics will be provided, including new medications that have been FDA- approved since the first edition.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Hurst & Co.
• 2nd edition
• Seitenzahl: 612
• Erscheinungstermin: 26. Februar 2016
• Englisch
• Abmessung: 251mm x 175mm x 25mm
• Gewicht: 953g
• ISBN-13: 9780199341016
• ISBN-10: 019934101X
• Artikelnr.: 47869866

Autorenporträt

Barbara S. Giesser, MD is Clinical Director at UCLA MS Clinical Service, David Geffen School of Medicine, Los Angles, CA.

Inhaltsangabe

* Part 1: Historical Background
* Chapter 1: The History of Multiple Sclerosis: From the Age of
Description to the Age of Therapy
* T. Jock Murray
* Part 2: Basic Science
* Chapter 2: Genetics and Epidemiology in Multiple Sclerosis
* Gabriele C. DeLuca, Richard L. Yates and A. Dessa Sadovnick
* Chapter 3: Neurophysiology of Multiple Sclerosis
* Jefferson C. Slimp
* Chapter 4: Immunology of Multiple Sclerosis
* Laura Piccio and Anne H. Cross
* Chapter 5: Taking a Microscopic Look at Multiple Sclerosis
* Yong Guo and Claudia F. Lucchinetti
* Part 3: Diagnosis and Prognosis
* Chapter 6: Diagnosis of Multiple Sclerosis
* Loren A. Rolak
* Chapter 7: Neuroimaging in Multiple Sclerosis
* Megan Esch and Nancy L. Sicotte
* Chapter 8: Cerebrospinal Fluid Profile Supporting a Clinical Definite
Multiple Sclerosis Diagnosis
* Mark Freedman and Mohammed Abdoli
* Chapter 9: Evoked Potentials
* Marc R. Nuwer
* Chapter 10: Temporal and Clinical Course of Multiple Sclerosis
* Erica Grazioli, Cornelia Mihai, and Bianca Weinstock-Guttman
* Chapter 11: Outcome Measures in Multiple Sclerosis
* Robert M. Herndon
* Part 4: Clinical Manifestations
* Chapter 12: Neuro-Ophthalmologic Manifestations of Multiple Sclerosis
* Shin C. Beh, Elliot M. Frohman, and Teresa Frohman
* Chapter 13: Cerebellar and Brainstem Dysfunction in Multiple
Sclerosis
* Angeli S. Mayadev and George H. Kraft
* Chapter 14: Disorders of Mobility in Multiple Sclerosis
* Scott Campea and Jodie K. Haselkorn
* Chapter 15: Management of Urinary and Bowel Dysfunction in Patients
with Multiple Sclerosis
* Ja-Hong Kim and Judy M. Choi
* Chapter 16: Assessment and Treatment of Sexual Dysfunction in
Multiple Sclerosis
* Frederick W. Foley
* Chapter 17: Gender and Reproductive Issues in Multiple Sclerosis
* Rhonda Voskuhl and Barbara S. Giesser
* Chapter 18: Cognitive Impairment and Mood Disturbances
* Nicholas G. LaRocca
* Chapter 19: Multiple Sclerosis and Pain
* Norman S. Namerow
* Chapter 20: Fatigue in Multiple Sclerosis
* Vikram Bhise, Leigh Charvet, and Lauren Krupp
* Chapter 21: Sleep Disorders in Multiple Sclerosis
* Tiffany J. Braley and Alon Y. Avidan
* Chapter 22: Pediatric Multiple Sclerosis
* J.M. Tillema, J. Graves, L.A. Benson, G.S. Aaen, A. Belman, J.
Parrish, B. Weinstock-Guttman, L. Krupp, T. Chitnis, and E. Waubant,
* Part 5: Therapeutics
* Chapter 23: Neuromyelitis Optica Spectrum Disorders
* Dean M. Wingerchuk
* Chapter 24: Multiple Sclerosis Nursing
* Kirstin Nygren and Gail Hartley
* Chapter 25: Immunomodulatory Agents for Relapsing-Remitting Multiple
Sclerosis
* Jessica F. Robb and Lawrence M. Samkoff
* Chapter 26: Immunosuppressive and Novel Therapies
* Barbara S. Giesser
* Chapter 27: Complementary and Alternative Medicine in Multiple
Sclerosis
* Allen C. Bowling
* Part 6: Psychosocial Issues
* Chapter 28: Living with Multiple Sclerosis: The Psychosocial
Challenges for Patients and Their Families Rosalind C. Kalb
* Chapter 29: Employment and Career Development Considerations
* Steven W. Nissen and Phillip D. Rumrill, Jr.
* Chapter 30: Legal Planning Issues
* Laura D. Cooper, Esq.
* Part 7: Research
* Chapter 31: Issues in the Design and Interpretation of Multiple
Sclerosis Clinical Trials
* Stephen Krieger, Ilana Katz Sand, Svenja Oynhausen, and Aaron Miller
* Chapter 32: Basic Science in Multiple Sclerosis: Progress and Promise
* Wendy Gilmore and Leslie P. Weiner